The FY2027 President's Budget requests $631.8M for Human Drugs, within Health & Human Services's Human Drugs account. That is down 7.7% on the FY2026 figure of $684.8M, which is the enacted appropriation.
FY2026–FY2027
| Fiscal year | Basis | Amount |
|---|---|---|
| FY2026 | enacted | $684.8M |
| FY2027 | request | $631.8M |
Bases are separate columns and are never summed into one figure.
Health & Human Services discretionary budget authority
From the OMB Public Budget Database — clean, summable, and the figure to cite for an agency total. It is the whole of Health & Human Services's discretionary request, not a total of the parsed lines above, and this page never adds the two together.
What this funds
Ensures the safety and efficacy of prescription, over-the-counter, generic, and biosimilar drugs, monitors marketed drugs, and oversees drug quality to prevent substandard or counterfeit products, through the Center for Drug Evaluation and Research.
Extracted from Food and Drug Administration, p. 12. Verbatim; nothing here is paraphrased.
Ask this budget line
Answers come from the figures on this page and nothing else. These dollars are parsed from Health & Human Services's Congressional Justification and are approximate — confirm anything that matters against the cited page.
This page carries the budget justification only. Contract obligations live at hitchintel.com/vendors; open solicitations at hitchintel.com/opportunities.